Literature DB >> 11750220

Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora.

G Reid1, D Beuerman, C Heinemann, A W Bruce.   

Abstract

Forty-two healthy women were randomized to receive one of three encapsulated Lactobacillus rhamnosus GR-1 plus Lactobacillus fermentum RC-14 probiotic dosage regimens or L. rhamnosus GG by mouth each day for 28 days. However, the vaginal flora, assessed by Nugent scoring, was only normal in 40% of the cases, and 14 patients had asymptomatic bacterial vaginosis. Treatment with L. rhamnosus GR-1/L. fermentum RC-14 once and twice daily correlated with a healthy vaginal flora in up to 90% of patients, and 7/11 patients with bacterial vaginosis converted to normal or intermediate scores within 1 month. Ingestion of L. rhamnosus GG failed to have an effect. This study confirms the potential efficacy of orally administered lactobacilli as a non-chemotherapeutic means to restore and maintain a normal urogenital flora, and shows that over 10(8) viable organisms per day is the required dose.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11750220     DOI: 10.1111/j.1574-695X.2001.tb00531.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  69 in total

1.  Local Probiotic Therapy for Vaginal Candida albicans Infections.

Authors:  Stefan Miladinov Kovachev; Rossitza Stefanova Vatcheva-Dobrevska
Journal:  Probiotics Antimicrob Proteins       Date:  2015-03       Impact factor: 4.609

2.  Optimization of Low-Cost Culture Media for the Production of Biomass and Bacteriocin by a Urogenital Lactobacillus salivarius Strain.

Authors:  María Silvina Juárez Tomás; Elena Bru; Birgitt Wiese; María Elena F Nader-Macías
Journal:  Probiotics Antimicrob Proteins       Date:  2010-03       Impact factor: 4.609

Review 3.  Taking probiotics during pregnancy. Are they useful therapy for mothers and newborns?

Authors:  Gregor Reid; Pirkka Kirjaivanen
Journal:  Can Fam Physician       Date:  2005-11       Impact factor: 3.275

Review 4.  Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies.

Authors:  Matthew E Falagas; Gregoria I Betsi; Theodoros Tokas; Stavros Athanasiou
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci.

Authors:  Jingru Li; Wenliang Wang; Stacey X Xu; Nathan A Magarvey; John K McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

6.  Vaginal lactic acid bacteria in healthy and ill bitches and evaluation of in vitro probiotic activity of selected isolates.

Authors:  Luis Delucchi; Martín Fraga; Karen Perelmuter; Esther Cidade; Pablo Zunino
Journal:  Can Vet J       Date:  2008-10       Impact factor: 1.008

Review 7.  Exploring a road map to counter misconceptions about the cervicovaginal microbiome and disease.

Authors:  Jean M Macklaim; Craig R Cohen; Gilbert Donders; Gregory B Gloor; Janet E Hill; Groesbeck P Parham; Jacques Ravel; Gregory Spear; Janneke van de Wijgert; Gregor Reid
Journal:  Reprod Sci       Date:  2012-05-21       Impact factor: 3.060

Review 8.  The role of probiotics in women with recurrent urinary tract infections.

Authors:  Turgay Akgül; Tolga Karakan
Journal:  Turk J Urol       Date:  2018-09-01

9.  DNA fingerprinting of Lactobacillus crispatus strain CTV-05 by repetitive element sequence-based PCR analysis in a pilot study of vaginal colonization.

Authors:  May A D Antonio; Sharon L Hillier
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

Review 10.  Potential uses of probiotics in clinical practice.

Authors:  Gregor Reid; Jana Jass; M Tom Sebulsky; John K McCormick
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.